GPCR Structure Therapeutics Inc.
Healthcare$39.19+1.03%ClosedMarket Cap: $2.26B
As of 2026-05-25
Insider Statistics (Q2 2026)
Acquisitions
0
Dispositions
2
Buy/Sell Ratio
0.00
Net Shares
-17,452
Shares Acquired
0
Shares Disposed
17,452
Total Bought ($)
$0.00
Total Sold ($)
$2.00
Recent Insider Trades
| Filing Date | Name | Type | Action | Shares | Price | Shares After |
|---|---|---|---|---|---|---|
| Thu Apr 23 | Lang Matthew | officer: COO & GC | Sell | 223,776 | $18.08 | 223,776 |
| Thu Apr 23 | Lang Matthew | officer: COO & GC | Sell | 184,614 | $0.00 | 184,614 |
| Thu Apr 23 | Lang Matthew | Sell | 0 | $0.00 | 0 | |
| Thu Apr 16 | FMR LLC | 10 percent owner, other: See Remark 1 | Sell | 16,085 | $0.00 | 32,171 |
| Thu Apr 16 | FMR LLC | 10 percent owner, other: See Remark 1 | Sell | 1,367 | $0.00 | 2,736 |
| Mon Mar 23 | Yoon Jun | officer: CHIEF FINANCIAL OFFICER | Sell | 128,892 | $16.82 | 128,892 |
| Mon Mar 23 | Yoon Jun | officer: CHIEF FINANCIAL OFFICER | Sell | 104,085 | $0.00 | 1,401,656 |
| Mon Mar 23 | Ma Yingli | officer: CHIEF TECHNOLOGY OFFICER | Sell | 40,278 | $16.82 | 40,278 |
| Mon Mar 23 | Ma Yingli | officer: CHIEF TECHNOLOGY OFFICER | Sell | 32,526 | $0.00 | 139,917 |
| Mon Mar 23 | Lin Xichen | officer: CHIEF SCIENTIFIC OFFICER | Sell | 53,703 | $16.82 | 53,703 |
| Mon Mar 23 | Lin Xichen | officer: CHIEF SCIENTIFIC OFFICER | Sell | 43,368 | $0.00 | 228,960 |
| Mon Mar 23 | Hall Ashley | officer: Chief Development Officer | Sell | 59,073 | $16.82 | 59,073 |
| Mon Mar 23 | Hall Ashley | officer: Chief Development Officer | Sell | 47,706 | $0.00 | 155,187 |
| Mon Mar 23 | Coll Crespo Blas | officer: CHIEF MEDICAL OFFICER | Sell | 93,984 | $16.82 | 93,984 |
| Mon Mar 23 | Coll Crespo Blas | officer: CHIEF MEDICAL OFFICER | Sell | 75,897 | $0.00 | 280,878 |